Table 1.
Clinical data of individuals involved in the study.
| BAL SARS-CoV-2+ N = 11 | BAL SARS-CoV-2 neg N = 23 | Non COVID-19− N = 21 | Total N = 55 | |
|---|---|---|---|---|
| Mean (IQR) | Mean (IQR) | Mean (IQR) | Mean (IQR) | |
|
Age (years) |
65 (69–76) |
64.5 (58–72) |
60 (45–72) |
63 (48–73) |
| N (%) | N (%) | N (%) | N (%) | |
| Gender Female Male |
3 (27) 8 (73) |
7 (30) 16 (70) |
8 (38) 13 (62) |
18 (32) 37 (68) |
| Outcome Survivor Non-survivor |
7 (64) 4 (36) |
14 (61) 9 (39) |
21 (100) 0 (0) |
42 (76) 13 (24) |
| Reason of admission Pneumonia/sepsis/ARDS Fever/cough Dyspnea Hypercapnic coma–pneumonia Sarcoidosis Bronchial congestion Psychomotor slowness Anosmia and ageusia Left adrenal mass N/A |
3 (27) 4 (36) 3 (27) 1 (9) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) |
8 (34) 5 (21) 8 (34) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (8) |
0 (0) 6 (28) 3 (14) 0 (0) 1 (4) 2 (9) 1 (4) 1 (4) 2 (9) 5 (23) |
11 (20) 15 (27) 14 (25) 1 (1) 1 (1) 2 (3) 1 (1) 1 (1) 2 (3) 7 (12) |
| Diabetes Yes No N/A |
1 (9) 9 (81) 1 (9) |
14 (60) 6 (26) 3 (13) |
0 (0) 17 (80) 4 (19) |
15 (27) 32 (58) 8 (14) |
| Obesity Yes No N/A |
1 (9) 9 (81) 1 (9) |
7 (30) 15 (65) 1 (4) |
2 (9) 18 (85) 1 (7) |
10 (18) 42 (76) 3 (5) |
| Cardiovascular disease Yes No N/A |
2 (18) 8 (72) 1 (9) |
5 (21) 17 (74) 1 (4) |
4 (19) 13 (62) 4 (19) |
11 (20) 38 (69) 6 (11) |
BAL, bronchoalveolar lavage; IQR, interquartile range; ARDS, acute respiratory distress syndrome. N/A, Non available.